Drug intelligence / Profile preview

FID 111421

Development stage: Unknown
Lead developer: Alcon
Modality: Small Molecules
Administration: Ophthalmic

Overview

FID 111421 is an investigational lubricant eye drop developed by Alcon Research for the treatment of dry eye syndrome. It was evaluated in a clinical trial (NCT00673959) to compare its acute comfort and blurring profile against Optive Lubricant Eye Drop in patients with dry eye. As an artificial tear product, it is intended to supplement the natural tear film and provide relief from symptoms such as ocular dryness and irritation. Specific details regarding its active ingredients or biological targets are not publicly available, though it likely functions through physical lubrication of the ocular surface.

Other names: Lubricant Eye Drop FID 111421

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on FID 111421.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FID 111421.

Explore the full profile